Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy.
Contreras-Sanz A, Negri GL, Reike MJ, Oo HZ, Scurll JM, Spencer SE, Nielsen K, Ikeda K, Wang G, Jackson CL, Gupta S, Roberts ME, Berman DM, Seiler R, Morin GB, Black PC.
Contreras-Sanz A, et al. Among authors: wang g.
Nat Commun. 2025 Feb 1;16(1):1240. doi: 10.1038/s41467-024-55665-1.
Nat Commun. 2025.
PMID: 39890781
Free PMC article.